7187landmark Papers in Rheumatology 1st Edition David G. I. Scott PDF Download
7187landmark Papers in Rheumatology 1st Edition David G. I. Scott PDF Download
https://ebookname.com/product/landmark-papers-in-
rheumatology-1st-edition-david-g-i-scott/
Get the full ebook with Bonus Features for a Better Reading Experience on ebookname.com
Instant digital products (PDF, ePub, MOBI) available
Download now and explore formats that suit you...
https://ebookname.com/product/landmark-papers-in-anaesthesia-1st-
edition-webster/
https://ebookname.com/product/oxford-case-histories-in-
rheumatology-1st-edition-joel-david/
https://ebookname.com/product/tinbergen-s-legacy-in-behaviour-
sixty-years-of-landmark-stickleback-papers-1st-edition-frank-
hippel-ed/
https://ebookname.com/product/the-hound-of-the-burgervilles-1st-
edition-e-j-russell/
Suicide in the Entertainment Industry An Encyclopedia
of 840 Twentieth Century Cases 1st Edition David K.
Frasier
https://ebookname.com/product/suicide-in-the-entertainment-
industry-an-encyclopedia-of-840-twentieth-century-cases-1st-
edition-david-k-frasier/
https://ebookname.com/product/religion-and-modern-society-
citizenship-secularisation-and-the-state-1st-edition-bryan-s-
turner/
https://ebookname.com/product/ultrafast-dynamics-and-laser-
action-of-organic-semiconductors-1st-edition-zeev-valy-vardeny/
https://ebookname.com/product/engaging-the-past-mass-culture-and-
the-production-of-historical-knowledge-alison-landsberg/
https://ebookname.com/product/classical-scholarship-and-
classical-learning-considered-with-especial-reference-to-
competitive-tests-and-university-teaching-1st-edition-john-
Cranial Osteopathy for Infants Children and Adolescents
A Practical Handbook 1st Edition Nicette Sergueef Do
https://ebookname.com/product/cranial-osteopathy-for-infants-
children-and-adolescents-a-practical-handbook-1st-edition-
nicette-sergueef-do/
Landmark Papers
in Rheumatology
Landmark Papers in… series
Titles in the series:
Edited by
1
1
Great Clarendon Street, Oxford, OX2 6DP,
United Kingdom
Oxford University Press is a department of the University of Oxford.
It furthers the University’s objective of excellence in research, scholarship,
and education by publishing worldwide. Oxford is a registered trade mark of
Oxford University Press in the UK and in certain other countries
© Oxford University Press 2015
The moral rights of the authors have been asserted
First Edition published in 2015
Impression: 1
All rights reserved. No part of this publication may be reproduced, stored in
a retrieval system, or transmitted, in any form or by any means, without the
prior permission in writing of Oxford University Press, or as expressly permitted
by law, by licence or under terms agreed with the appropriate reprographics
rights organization. Enquiries concerning reproduction outside the scope of the
above should be sent to the Rights Department, Oxford University Press, at the
address above
You must not circulate this work in any other form
and you must impose this same condition on any acquirer
Published in the United States of America by Oxford University Press
198 Madison Avenue, New York, NY 10016, United States of America
British Library Cataloguing in Publication Data
Data available
Library of Congress Control Number: 2015932388
ISBN 978–0–19–968837–1
Printed and bound by
CPI Group (UK) Ltd, Croydon, CR0 4YY
Oxford University Press makes no representation, express or implied, that the
drug dosages in this book are correct. Readers must therefore always check
the product information and clinical procedures with the most up-to-date
published product information and data sheets provided by the manufacturers
and the most recent codes of conduct and safety regulations. The authors and
the publishers do not accept responsibility or legal liability for any errors in the
text or for the misuse or misapplication of material in this work. Except where
otherwise stated, drug dosages and recommendations are for the non-pregnant
adult who is not breast-feeding
Links to third party websites are provided by Oxford in good faith and
for information only. Oxford disclaims any responsibility for the materials
contained in any third party website referenced in this work.
Preface
The rheumatism is a common name for many aches and pains, which have yet got no peculiar ap-
pellation, though owing to very many different causes.
(William Heberden (1710–1801) Commentaries on the History and Cure of Disease, Chapter 79
(1802)).
William Heberden in many respects summarized the state of rheumatic disease nomen-
clature and classification in 1802 with the statement quoted above. At that time, probably
only gout was clearly distinguished from many types of aches and pains. In the commen-
taries he also gives the first description of the bony nodes over the distal interphalangeal
joints—‘What are those little hard knobs, about the size of a small pea, which are frequently
seen upon the fingers, particularly a little below the top, near the joint?’ He does not under-
stand their aetiology but recognizes them not to be linked with psoriasis. During the late
eighteenth and nineteenth centuries, descriptions of disease patterns that we now recog-
nize began to be made. Sir Archibald Garrod in 1859 gave the name ‘rheumatoid arthritis’
to a disease that, although around for many years, had no nomenclature and up until that
stage had been described as ‘rheumatic gout’, ‘chronic rheumatism’, and ‘rheumalgia’. The
first steps in the scientific investigation of arthritis were also made around this time; for ex-
ample, Garrod differentiated gouty arthritis using the presence of serum hyperuricaemia.
This process has continued up to the present day, with differentiation of further types of ar-
thritis, using both traditional methods of clinical pattern recognition combined with im-
proved investigative techniques, for example, the clear differentiation of inflammation due
to synovitis from that due to enthesial inflammation using MRI, and better understanding
of causation, for example, the recognition that a certain form of inflammatory arthritis of
children is due to borrelia infection. As the study of rheumatic disease has become more
scientific simple descriptions of disease patterns have become inadequate for clinical stud-
ies and this has led to the development of validated diagnostic and classification systems
for many of the rheumatic diseases.
Treatment in Heberden’s day was limited and primarily consisted bleeding or purg-
ing, although the antipyretic properties of cinchona bark were recognized. The only
specific therapy for a form of arthritis then was colchicine for gout, which had been
used since the time of Hippocrates. Garrod suggested that hyperuricaemia could be
controlled by limiting dietary intake of purines. The nineteenth century saw the de-
velopment of aspirin and early analgesics. The twentieth century saw the introduction
of corticosteroids—for which Hench won the Nobel prize—immunosuppressive drugs,
and most recently the products of the biotechnology revolution, monoclonal antibodies
and fusion proteins.
vi PREFACE
The aim of this book is to provide both practising and trainee rheumatologists with an
overview of the history of their specialty by presenting some of the key papers, together
with brief commentary as to why the paper is important. The authors were asked to select
up to ten papers in their field covering in their opinion key developments. The papers
range from initial descriptions of disease up to very recent innovations in our scientific
understanding of aetiopathogenesis and therapy.
Richard A. Watts
David G. I. Scott
Acknowledgements
We are grateful to Eloise Moir-Ford and James Oates of Oxford University Press for all
their unstinting help and enthusiasm during the production of this book. Without them,
it would never have happened.
Our families, particularly Lesley and Dee, have been very supportive during the editing
process and we are indebted to them.
Richard A. Watts
David G. I. Scott
Contents
Contributors xv
1 Epidemiology and genetics 1
James Bluett, Suzanne Verstappen, and Deborah Symmons
Introduction 1
Paper 1.1: Radiological assessment of osteoarthritis—the Kellgren and Lawrence
score 4
Paper 1.2: The association between rheumatoid arthritis and lymphoma 7
Paper 1.3: The American Rheumatism Association 1987 revised criteria for the
classification of rheumatoid arthritis 10
Paper 1.4: The global burden of disease 15
Paper 1.5: The shared epitope hypothesis 19
Paper 1.6: The association between protein tyrosine phosphatase 22 and rheumatoid
arthritis 23
Paper 1.7: The Wellcome Trust genome-wide association study of rheumatoid
arthritis 25
Paper 1.8: Five amino acids in three proteins encoded by MHC genes explain most
of the association between the MHC locus and seropositive rheumatoid
arthritis 27
Paper 1.9: High-density genetic mapping identifies new susceptibility loci for
rheumatoid arthritis 30
Paper 1.10: Gene–environment interaction in the aetiology of rheumatoid arthritis 32
2 Rheumatoid arthritis 37
Elena Nikiphorou and Adam Young
Introduction 37
Landmark paper selection 38
Paper 2.1: Rheumatoid arthritis in a population sample 39
Paper 2.2: Judging disease activity in clinical practice in rheumatoid arthritis: first
steps in the development of a disease activity score 42
Paper 2.3: Measurement of patient outcome in rheumatoid arthritis 48
Paper 2.4: Effects of cortisone acetate and pituitary adrenocorticotropic hormone on
rheumatoid arthritis, rheumatic fever, and certain other conditions 53
Paper 2.5: Efficacy of low-dose methotrexate in rheumatoid arthritis 56
Paper 2.6: Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal
antibody) versus placebo in rheumatoid arthritis patients receiving
concomitant methotrexate: a randomized phase III trial 59
Paper 2.7: Taking mortality in rheumatoid arthritis seriously—predictive markers,
socio-economic status, and co-morbidity 62
x CONTENTS
Paper 2.8: Rheumatoid arthritis: treatment which controls the C-reactive protein
and erythrocyte sedimentation rate reduces radiological progression 65
Paper 2.9: Effect of a treatment strategy of tight control for rheumatoid arthritis
(the TICORA study): a single-blind randomized controlled trial 68
Paper 2.10: Clinical and radiographic outcomes of four different treatment strategies
in patients with early rheumatoid arthritis (the BeSt study): a randomized,
controlled trial 73
3 Spondyloarthropathies 77
Carmel Stober and Hill Gaston
Introduction 77
Paper 3.1: Recognition of psoriatic arthritis 79
Paper 3.2: Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s
disease, the intestinal arthropathies, and Behçet’s syndrome 83
Paper 3.3: The discovery of the association between ankylosing spondylitis and
HLA-B27 88
Paper 3.4: A syndrome of seronegative enthesopathy and arthropathy in children 91
Paper 3.5: Yersinia antigens in synovial-fluid cells from patients with reactive
arthritis 95
Paper 3.6: Transgenic expression of HLA-B27 in rats induces various inflammatory
disorders with clear links to spondyloarthritis 98
Paper 3.7: The evolution of spondyloarthropathies in relation to gut histology 103
Paper 3.8: A hypothesis that enthesitis is the primary pathological process occurring
in spondylarthropathy 108
Paper 3.9: First, and dramatic, indication of the effectiveness of tumour necrosis
factor α blockade in ankylosing spondylitis 113
Paper 3.10: Additional genes which influence susceptibility to ankylosing spondylitis,
including ERAP1, which affects HLA-B27 assembly 117
4 Systemic lupus erythematosus 121
Benjamin Parker and Ian N. Bruce
Introduction 121
Paper 4.1: Common overlapping pathological features of systemic autoimmune
rheumatic diseases 122
Paper 4.2: The LE cell phenomenon 125
Paper 4.3: Complement deposition demonstrated in systemic lupus erythematosus
tissue 128
Paper 4.4: Premature cardiovascular disease in systemic lupus erythematosus
patients 131
Paper 4.5: Long-term trials demonstrate the efficacy of immunosuppression for lupus
nephritis 135
Paper 4.6: Development of classification criteria for systemic lupus erythematosus 139
Paper 4.7: Interferon implicated in immunopathogenesis of systemic lupus
erythematosus 142
Paper 4.8: Successful clinical trials of belimumab in systemic lupus erythematosus 144
CONTENTS xi
Paper 4.9: The first description of the association between the lupus anticoagulant
and thrombosis in systemic lupus erythematosus 147
Paper 4.10: The impact of withdrawal of hydroxychloroquine in stable systemic lupus
erythematosus 150
5 Vasculitis 153
Haroon Khan, David G. I. Scott, and Richard A. Watts
Introduction 153
Paper 5.1: Earliest description of systemic vasculitis 155
Paper 5.2: Pathology of giant cell arteritis 157
Paper 5.3: Original description of Kawasaki disease 160
Paper 5.4: Relationship between infection with hepatitis B virus and polyarteritis
nodosa 164
Paper 5.5: The discovery of anti-neutrophil cytoplasmic antibodies as a marker
of Wegener’s granulomatosis 167
Paper 5.6: Definitions and nomenclature of vasculitis—the Chapel Hill Consensus
Conferences, 1994 and 2012 170
Paper 5.7: Development of assessment tools for systemic vasculitis 176
Paper 5.8: Cyclophosphamide as treatment for systemic vasculitis 179
Paper 5.9: Maintenance therapy for systemic vasculitis 181
Paper 5.10: Biologic therapy for systemic vasculitis 184
6 Osteoarthritis 189
Iain Goff and Fraser Birrell
Introduction 189
Paper 6.1: The first description of nodal osteoarthritis 191
Paper 6.2: Arthroplasty of the hip 193
Paper 6.3: Prevalence of symptoms and structural changes of osteoarthritis in the
population 197
Paper 6.4: Effect of age on the prevalence of osteoarthritis 201
Paper 6.5: Predicting progression of osteoarthritis using imaging 205
Paper 6.6: Aerobic exercise and resistance exercise versus an education programme
in knee osteoarthritis 207
Paper 6.7: Glucosamine sulphate for symptoms and progression of knee
osteoarthritis 210
Paper 6.8: Arthroscopy versus sham arthroscopy in knee osteoarthritis 214
Paper 6.9: Association of pain and radiographic change 216
Paper 6.10: Efficacy and toxicity of paracetamol 219
Paper 7.3: Gout-associated uric acid crystals activate the NALP3 inflammasome 234
Paper 7.4: Dietary risk factors for gout 237
Paper 7.5: Gout and coronary heart disease: the Framingham Study 242
Paper 7.6: Allopurinol therapy for gout 246
Paper 7.7: Febuxostat compared with allopurinol in patients with hyperuricemia
and gout 251
Paper 7.8: Can acute attacks of gout be prevented by optimum suppression
of urate? 255
Paper 7.9: Mutations in ANKH cause chondrocalcinosis 258
Paper 7.10: Clinical and radiographic features of pyrophosphate arthropathy 263
Index 357
Contributors
Introduction
Epidemiology
Epidemiology is the study of the distribution and determinants of disease in human popu-
lations. It is applied to describe the prevalence and incidence of a disease, to identify pre-
dictors (genetic and environmental) of the development of disease, and to describe the
consequences of a disease. Understanding the distribution and the burden of diseases
helps health policy makers and the general public to understand the impact of diseases
and injuries across different regions of the world and the need for specific intervention
programmes and better distribution of health care resources. We selected Paper 1.4 as an
excellent example of the estimation of the occurrence/burden of rheumatic and muscu-
loskeletal disorders (RMDs). It was published in The Lancet in 2012 as one of a number
of papers on the global burden of disease, and possible risk factors. This paper showed
that, over the last two decades, the disability-adjusted life years (DALYs) for rheumatoid
arthritis, neck and back pain, and osteoarthritis have increased, whereas the death rate for
rheumatoid arthritis has decreased by ~10%.
Although the Global Burden of Disease study provides the best available estimate of
disease occurrence, these papers also illustrate the challenges epidemiologists face when
estimating the impact of a disease in different countries, and amalgamating data from a
variety of sources, often without case validation. Ideally, to determine prevalence and inci-
dence of a disease, it is important to use validated tools for case definition. We selected two
key papers (Papers 1.1 and 1.2) which demonstrate the development of case definitions for
RMDs. The Kellgren and Lawrence radiological scoring system for osteoarthritis is one of
the first examples of a validated tool in rheumatology. Although the scoring system has
undergone a few minor changes since its introduction 50 years ago, it is often still used to
estimate and compare prevalence rates for osteoarthritis and to assess radiographic dam-
age over time in populations with osteoarthritis in different settings. For rheumatoid arth-
ritis patients, a series of classification criteria sets have been developed by the American
Rheumatism Association/American College of Rheumatology. The 1987 criteria set have
been used extensively, not only to estimate the incidence and prevalence of rheumatoid
2 Epidemiology and genetics
arthritis but also as part of the entry criteria to clinical trials and observational studies.
In the last decade there has been a shift towards earlier classification and treatment of
rheumatoid arthritis. Because of their increased specificity in early rheumatoid arthritis,
the 2010 American College of Rheumatology/European League Against Rheumatism cri-
teria for rheumatoid arthritis are beginning to replace the 1987 criteria in this setting.
Epidemiology studies are also suitable to describe the occurrence and predictors of
long-term consequences of a disease (e.g. co-morbidities, disability, and mortality). Stand-
ardized mortality ratios (SMRs) or standardized incidence ratios (SIRs) are often calcu-
lated, using data from the general population as the reference, to quantify the excess risk
of co-morbidities. Paper 1.3 illustrates one of the first examples of the use of population
registers and record linkage in RMDs. It examined the risk of lymphoma, leukaemia, and
myeloma in patients with rheumatoid arthritis compared to the general population. To
date, this remains one of the largest observational studies showing an increased risk of
lymphoproliferative malignancies in patients with rheumatoid arthritis.
Genetic epidemiology
A genetic basis underlying a number of RMDs has been established using twin and family
studies. Using rheumatoid arthritis as an exemplar, we have selected and go on to discuss
the milestones that have produced step changes in our knowledge of the genetics under-
lying the development of disease.
Paper 1.5, published in 1987 by Gregerson et al., described the shared epitope hypothesis
to explain the association of the human leukocyte antigen (HLA) DRB1 alleles as the major
risk factor for rheumatoid arthritis; the paper is still widely cited and, until very recently, no
other hypotheses could better explain the association observed. The next major milestone
did not occur until 2004, when Begovich et al. (Paper 1.6) discovered the second-largest
genetic risk for the development of rheumatoid arthritis: a protein-coding change in the
PTPN22 gene. Their research not only identified this genetic variant but also investigated
its biological impact and determined that there is a genetic difference between seropositive
and seronegative rheumatoid arthritis, a potential clue in the disease pathogenesis.
As technological capabilities advanced, in 2007 a consortium of scientists from all over
the UK came together to test genetic variants spanning the whole genome (a genome-wide
association study) in order to establish which genetic markers are associated with a num-
ber of autoimmune diseases, including rheumatoid arthritis. The study (Paper 1.7) val-
idated previous research findings and revealed nine new genetic variants associated with
rheumatoid arthritis, greatly expanding our knowledge of the disease. The results from
the Wellcome Trust Case Control Consortium represented a major advance in the gen-
etic understanding of disease, confirmed the importance of large sample sizes to enhance
power to detect modest genetic effects, and demonstrated how a large group of scientists
and clinicians can work together to enhance our understanding of disease.
From whole genome scanning, genetic studies have returned to focusing on particular
sections of the genome. In 2012, technology and expanding cohort numbers enabled the
investigation of the HLA region with fine mapping to determine the true disease-causing
INTRODUCTION 3
variants. Raychaudhuri et al. (Paper 1.8) discovered three genetic variants within the HLA
DRB1 gene that increase the risk of rheumatoid arthritis independently of each other and
together and explain the association observed better than the previous shared epitope hy-
pothesis. The variants lie within the peptide-binding grove of the HLA molecule, giving
a vital clue to the importance of antigen presentation in the development of seropositive
rheumatoid arthritis. Outside the shared epitope region, researchers have fine-mapped
areas of previous interest, and in 2012 Eyre et al. (Paper 1.9) characterized, by fine map-
ping, over 40% of the known susceptibility areas to rheumatoid arthritis in one analysis.
This paper was among the first to demonstrate, in rheumatoid arthritis, how genetic stud-
ies can identify novel targets for disease treatment.
Gene–environment interaction
The paradigm for the development of RMDs is that one or more environmental risk factors
act in a genetically predisposed host to produce the disease phenotype. This paper (Paper
1.10) was the first to illustrate, statistically, that a genetic risk factor (the shared epitope)
and an environmental risk factor (smoking) interact to enhance disease susceptibility for
rheumatoid arthritis.
4 Epidemiology and genetics
Purpose
To develop and validate a system for scoring X-rays for the presence and severity of
osteoarthritis.
Study design
The authors selected standard radiographs to represent 5 grades of osteoarthritis: none (0),
doubtful (1), mild (2), moderate (3), and severe (4) for 11 joint areas. The standard radio-
graphs for Grades 1–4 for the distal interphalangeal (DIP) joints, proximal interphalan-
geal (PIP) joints, metacarpophalangeal (MCP) joints, first carpometacarpal (CMC) joints,
wrist, cervical spine, hip, and knee are reproduced in this paper—a forerunner of the much
used Atlas of Standard Radiographs [1]. The other joint areas assessed were the dorsal and
lumbar spine and the feet. Verbal definitions of the radiological features and the grading
criteria are shown in Table 1.1.
Radiological features
- Formation of osteophytes on the joint margins or, in case of the knee joint, on the tibial spines.
- Periarticular ossicles; these are found chiefly in relation to the distal and proximal interpharangeal
joints.
- Narrowing of joint cartilage associated with sclerosis of subchondral bone.
- Small pseudocystic areas with sclerotic walls situated usually in the subchondral bone.
- Altered shape of the bone ends, particular in the head of the femur.
Grading system:
- Grade 0 (none): No features of osteoarthritis.
- Grade 1 (doubtful): Minute osteophyte, doubtful significance.
- Grade 2 (minimal): Definite osteophyte, unimpaired joint space.
- Grade 3 (moderate): Moderate diminution of joint space.
- Grade 4 (severe): Joint space greatly impaired with sclerosis of subchondral bone.
Source data from Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957
Dec;16(4):494–502.
PAPER 1.1: RADIOLOGICAL ASSESSMENT OF OSTEOARTHRITIS 5
The inter-observer and intra-observer reliability of this scoring system was evaluated by
Kellgren and Lawrence themselves using X-rays from a survey of rheumatic diseases in the
Leigh, Lancashire, population, UK. X-rays of a random sample of 85 people aged 55–64
were read by the two observers by comparing these with the standard radiographs. Eleven
joint areas were evaluated and the intervals between the combined and the independent
readings were two months and one month, respectively, after the independent reading.
Results
Inter-observer agreement ranged from 0.10 for the wrist to 0.83 for the knee. Intra-
observer agreement was higher and ranged from 0.42 for the dorso-lumbar spine to 0.88
for the MCP joints. Although, for most joints, the agreement was high, the estimated preva-
lence of the disease varied widely because of the cumulative effect of observer bias (±31%).
20–24 to 84.3% in women aged 75–79. In men a similar increase was observed, from 0.7%
to 84.8%. Seventy-five per cent of the women had osteoarthritis (grade ≥2) of their DIP
joints. Severe osteoarthritis was most common in those aged >45 years, and the prevalence
rate exceeded the 20% for the cervical spine and lumbar spine, DIP joints of hands, and,
in women only, MCP joints, first CMC joints, first metatarsophalangeal joints, and knees.
Since the Kellgren and Lawrence score is based on an ordinal scoring system, it is more
difficult to determine annual progression than to assess changes in joint space narrowing
over time. In a systematic review, the annual radiographic progression was calculated as
percentage with change of at least one grade [7]. Including both data from observational
studies and clinical trials, the overall mean risk of Kellgren and Lawrence annual progres-
sion of at least one grade was 5.6 ± 4.9%, with a higher risk associated with shorter disease
duration, and with cohorts that included both incident and prevalent cases. This overview
also showed that patients with a Kellgren and Lawrence score ≥2 at inclusion into a study
have a higher risk of progression than those recruited with a Kellgren and Lawrence score
≥1 (6.2% vs 3.3%).
References
1 Kellgren JH., Lawrence JS. The epidemiology of chronic rheumatism. Atlas of standard radiographs.
Oxford: Blackwell Scientific;1963.
2 Spector TD, Cooper C. Radiographic assessment of osteoarthritis in population studies: whither
Kellgren and Lawrence? Osteoarthr Cartil 1993;1(4):203–6.
3 Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006;20(1):3–25.
4 Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr
Cartil 2007;15(Suppl A):A1–56.
5 Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip,
and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum
1995;38(8):1134–41.
6 van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of
osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population
with that in 10 other populations. Ann Rheum Dis 1989;48(4):271–80.
7 Emrani PS, Katz JN, Kessler CL, et al. Joint space narrowing and Kellgren-Lawrence progression in
knee osteoarthritis: an analytic literature synthesis. Osteoarthr Cartil 2008;16(8):873–82.
PAPER 1.2: RHEUMATOID ARTHRITIS AND LYMPHOMA 7
Purpose
To compare the incidence of malignancy in patients entitled to free medication for
rheumatoid arthritis in Finland with that in the general Finnish population matched for
age and gender.
Population studied
The population studied comprised patients on the Finnish Social Insurance Institution’s
Population Data Register (started in 1965) as being entitled to reimbursable medication
for ‘rheumatoid arthritis’. The term ‘rheumatoid arthritis’ included systemic connective
tissue disease until 1970 (1.7% of cases) and ankylosing spondylitis since 1970 (2.2% of
all cases).
Study design
This paper describes a longitudinal observational study using population registers. Details
of patients entitled to reimbursable medication for ‘rheumatoid arthritis’ from 1967–1973
were linked to the Finnish Cancer Registry in order to identify all new cancer cases diag-
nosed from 1 January 1967 or the date of the first rheumatoid arthritis prescription until
31 December 1967 or death. The numbers of various types of malignancy observed were
compared with those expected in the general Finnish population matched for age and sex.
Results
The study follows 11,483 men and 34,618 women with ‘rheumatoid arthritis’ for 213,911
years. The authors report 1,202 incident malignancies as compared to the 1,137.89
expected.
The authors report that the incidence of cancer of the respiratory organs, lymphoma,
myeloma, and leukaemia was increased in men with rheumatoid arthritis (Table 1.2). Al-
though the overall incidence of malignancy was not increased in women, the incidence of
Hodgkin’s disease, lymphoma, and myeloma was increased.
In addition, the paper was published before the widespread calculation of relative risk and
95% CI. We have included these in Table 1.2 for completeness. In addition the authors do
not address the possible reasons for the link beyond speculating that in some way patients
are susceptible to both rheumatoid arthritis and lymphoproliferative malignancies.
References
1 Parikh-Patel A, White RH. Risk of cancer among rheumatoid arthritis patients in California. Cancer
Causes Control 2009;20(6):1001–10.
2 Smitten AL, Simon TA, Hochberg M, Suissa S. A meta-analysis of the incidence of malignancy in
adult patients with rheumatoid arthritis. Arthritis Res Ther 2008;10(2):45.
3 Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with
increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54(3):692–701.
4 Asten P, Barrett J, Symmons D. Risk of developing certain malignancies is related to duration
of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol
1999;26(8):1705–14.
10 Epidemiology and genetics
Purpose
The 1987 American Rheumatism Association/American College of Rheumatology criteria
for rheumatoid arthritis were developed in order to improve specificity and sensitivity and
additionally to improve simplicity, as compared to the 1958 American Rheumatism Asso-
ciation criteria. [1–4]
Study design
The evaluated criteria set included the individual items of the old American Rheumatism
Association and New York criteria (Table 1.3) for rheumatoid arthritis and items con-
sidered to be important by the committee following a Delphi method procedure. Two stat-
istical approaches were applied to develop the classification criteria. First, combinations of
variables which were most sensitive and specific to the classification of rheumatoid arth-
ritis were selected by means of Boolean algebra; for example, a patient would be classi-
fied as having rheumatoid arthritis if at least X out of Y criteria were present. The second
method involved selecting variables which best discriminated rheumatoid arthritis pa-
tients from controls using a ‘classification tree’. All analyses were repeated for patients with
‘new’ disease and for patients with established disease. Finally, the specificity of the two
methods was tested against 137 consecutive subjects enrolled in a USA prospective study.
Results
Items selected by the committee included morning stiffness, pain on motion in joints,
swelling in ≥3 joint areas, symmetric swelling, subcutaneous nodules, abnormal rheuma-
toid factor, and radiological findings. The accuracy, calculated as the mean of sensitivity
and specificity, of these individual items varied from 50.3 for pain on motion of the distal
interphalangeal joint to 87.4 for swelling of ≥3 joint areas upon physical examination. The
PAPER 1.3: AMERICAN RHEUMATISM ASSOCIATION REVISED CRITERIA 11
Table 1.4 The 1987 revised criteria for the classification of rheumatoid arthritis (list format)*
Criterion Definition
1. Morning stiffness Morning stiffness in and around the joints, lasting at least one hour before
maximal improvement.
2. A
rthritis of three At least three joint areas simultaneously have had soft tissue swelling or
or more joint areas fluid (not bony overgrowth alone) observed by a physician. The 14 possible
areas are right or left PIP, MCP < wrist, elbow, knee, ankle, and MTP joints.
3. Arthritis of hand joints At least one area swollen in a wrist, MCP, or PIP joint.
4. Symmetric arthritis Simultaneous involvement of the same joint areas (as defined in Criterion 2)
on both sides of the body (bilateral involvement of PIP, MCP, or MTP joints is
acceptable without absolute symmetry).
5. Rheumatoid nodules Subcutaneous nodules, over bony prominences, or extensor surfaces, or in
juxtaarticular regions, observed by a physician.
6. S erum rheumatoid Demonstration of abnormal mounts of serum rheumatoid factor by any
factor method for which the result has been positive in <5% of normal controls.
7. Radiographic changes Radiographic changes typical of rheumatoid arthritis on posterior/anterior
hand and wrist radiographs, which must include erosions or unequivocal
bony decalcification localized in or marked adjacent to the involved joints
(osteoarthritis changes alone do not qualify).
* For classification purpose, a patient shall be said to have rheumatoid arthritis if he/she has satisfied at least four of
these seven criteria. Criteria 1 through 4 must have been present for at least 6 weeks. Patients with Criterion 2 clin-
ical diagnoses are not excluded. Designation as classic, definite, or probable rheumatoid arthritis is not to be made;
DIP, distal interphalangeal; PIP, proximal interphalangeal; MCP, metacarpophalangeal; MTP, metatarsophalangeal.
Source data from Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised cri-
teria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 Mar;31(3):315–24.
12 Epidemiology and genetics
final seven criteria and their definitions included in the 1987 criteria for rheumatoid arth-
ritis are shown in Table 1.4. To be classified as having rheumatoid arthritis, patients had
to satisfy at least four out of these seven criteria. The criteria included in the classification
tree were slightly different and did not include morning stiffness or rheumatoid nodules
(Figure 1.1) [5]. Compared to the 1958 American Rheumatism Association and New York
criteria, the sensitivity and specificity improved for the revised classification criteria and
classification tree to 91.2% and 93.5%, respectively, for sensitivity and to 89.3% and 89.3%,
respectively, for specificity.
Arthritis of 3
or more joints
Yes No
X-ray changes RF
(swelling of MCP joints) (wrist swelling)
No Yes
RF
(wrist swelling) Symmetry
No No
Yes No Yes No
RA RA RA IP RA RA IP IP
Fig. 1.1 Tree format of the American College of Rheumatology 1987 criteria for the classification
of rheumatoid arthritis, as applied to patients with inflammatory polyarthritis; IP, inflammatory
polyarthritis; MCP, metacarpophalangeal; RA, rheumatoid arthritis; RF, rheumatoid factor.
last decade it has been shown that early and aggressive treatment of inflammatory arthritis
is clinically more beneficial, resulting in less accrual joint damage and long-term disability
[7–9]. If the 1987 criteria for rheumatoid arthritis are used to determine which patients
should be included in treatment studies, or even as a guide in clinic for treatment deci-
sions, those who might benefit most from early intensive treatment would be excluded.
For these reasons, new criteria showing better specificity were developed and published
in 2010 [10–12].
A further criticism is in the selection of the comparison cohort. Many of the patients
included in the comparison cohort had non-inflammatory conditions which are easily
distinguishable from rheumatoid arthritis. In studies of criteria development, the com-
parison group should have diseases which have features in common with the disease
under study.
Finally, unlike the 1958 criteria, there are no exclusions included in the 1987 criteria.
Thus it is possible, for example, for someone with classical gout to also be classified as hav-
ing rheumatoid arthritis if they happen to fulfil the 1987 criteria.
References
1 Bennett GA, Cobb S, Jacox R, Jessar RA, Ropes MW. Proposed diagnostic criteria for rheumatoid
arthritis. Bull Rheum Dis 1956;7(4):121–4.
2 Cobb S, Merchant WR, Warren JE. An epidemiologic look at the problem of classification in the field
of arthritis. J Chronic Dis 1955;2(1):50–4.
3 Cobb S, Thompson DJ, Rosenbaum J, Warren JE, Merchant WR. On the measurement of prevalence
of arthritis and rheumatism from interview data. J Chronic Dis 1956;3(2):134–9.
4 Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. 1958 Revision of diagnostic criteria for
rheumatoid arthritis. Bull Rheum Dis 1958;9(4):175–6.
5 Lunt M, Symmons DP, Silman AJ. An evaluation of the decision tree format of the American College
of Rheumatology 1987 classification criteria for rheumatoid arthritis: performance over five years in a
primary care-based prospective study. Arthritis Rheum 2005;52(8):2277–83.
6 Banal F, Dougados M, Combescure C, Gossec L. Sensitivity and specificity of the American College
of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration:
a systematic literature review and meta-analysis. Ann Rheum Dis 2009;68(7):1184–91.
7 Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early
arthritis: report of a task force of the European Standing Committee for International Clinical Studies
Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66(1):34–45.
Exploring the Variety of Random
Documents with Different Content
242 DESSERTS, CUSTARDS AND CREAMS TRIFLE Sponge
cake, soaked in sherry wine; chopped figs and a pint of almond
custard, large cup of strawberry jam, one pint of cream, whipped,
for top. GINGER CREAM Cut four ounces of prepared ginger in dice;
put one ounce of gelatine into a saucepan with a pint of milk and
four tablespoonfuls of sugar. Let it boil slowly, stirring all the time till
the gelatine is dissolved, then add ginger. When cool add one pint of
whipped cream. Pour in dampened mould to form. PINEAPPLE
CREAM One can of pineapple (grated), three ounces of loaf sugar,
half a pint of water, three-quarters of an ounce of gelatine, one and
a half pints of cream. Drain syrup from pineapple and put in half a
pint of water and sugar in sauce-pan. When dissolved add fruit,
boiling ten minutes, then add gelatine and boil ten minutes longer.
When entirely cold add the cream, well whipped, and pour in
moulds. RUSSIAN CREAM 1 box gelatine. f cups sugar. 1 qt. milk. 4
eggs. Soak gelatine in cup of milk, add to rest of milk, heated. Add
yolks of eggs and sugar. Cook until smooth. Remove from stove and
add whites of eggs. Pour in mould to cool. SAUCE Three eggs, three
ounces sugar, half pint of whipped cream measured after being
whipped, half glass of chartreuse ; whip eggs and sugar over boiling
water for ten minutes; then remove and whip until cold, then add
cream and chartreuse.
DESSERTS, CUSTARDS AND CREAMS 243 SOUFFLE 2 oz.
butter. oz. flour. Yolks of 4 eggs. Whites of 6 eggs. 1 teaspoonful
vanilla. 2 oz. chocolate. 2 oz. sugar. 1 gill cream. Melt butter and
flour, then add cream; cook two minutes; add chocolate and stir till
melted. Remove from fire and let cool, then add yolks and, just
before steaming, add whites stiffly beaten; fold them in gently;
steam one hour and a half. Steam in mould placed in saucepan of
hot water; let water come half way up mould ; put mould in bottom
of saucepan and cover with a greased paper, and then cover
saucepan. Do not let water boil. Six lemons, four eggs (the whites),
two pints sugar. Make a thick syrup of one pint sugar and about one
pint water; when cold, thin with the juice of six lemons, and water
enough to make it a rich lemonade. When it is half frozen add boiled
icing, made as follows: One pint sugar moistened with water, and
boiled until it is a soft candy; whilst hot add the stiff beaten whites
of four eggs. Flavor with vanilla and a little citric acid or cream tartar,
and beat hard until thick and smooth, and add to the half frozen
lemonade. Soak gelatine for several hours in pint of cold water, grate
the rinds of lemons, add with the juice of the lemons the LEMON
SHERBET WINE JELLY 1 box gelatine. 1 pt. cold water. 1 cup sugar.
2 lemons. 2 eggs. 1 pt. hot water. ^ cup wine. Wine glass whisky.
244 DESSERTS, CUSTARDS AND CREAMS whites and shells
of two eggs, hot water (not boiling), wine, whisky, some cinnamon
and sugar and let all boil ; skim and strain through flannel bag, add
large cup sugar and remainder of wine and put in mould to cool.
LEMON JELLY 1 box gelatine. 1 pt. sugar. 1 pt. hot water. 2 lemons,
juice and rind. ■J pt. wine. Whites 3 eggs. Soak gelatine for one
hour in a pint of cold water, then add hot water, wine, sugar, lemons,
juice and thinly pared rind. Boil for one-half a minute and strain.
This with wine left out. Whites of three eggs (beaten to a stiff froth
and stirred in before quite cold), and put in mould. FRUIT JELLY 1
box gelatine. 1 cup sugar. 2 lemons. •J pt. cold water. pts. boiling
water. Fruits : Peaches, bananas, oranges, sliced. Dissolve gelatine in
one-half pint cold water, add sugar and lemon juice, with boiling
water. Let this stand until the jelly begins to thicken, then pour a
little into the mould: place on it a layer of peaches, cut any shape
desired. Put in more jelly and fruit, alternately until the mould is
filled. Place on ice to set and serve with whipped cream. Care should
be taken to allow each layer of fruit and jelly to set before putting in
another, so that the fruit will not fall together. PRUNE JELLY One pint
of prunes, half a box of gelatine, sugar to taste, and a pinch of salt.
Wash the prunes, then boil slowly till
DESSERTS, CUSTARDS AND CREAMS 245 soft in sufficient
water to cover. Take out the stones, sweeten to taste ; add essence
of vanilla, or if preferred the juice and rind of a lemon, and the juice
of two oranges. Soak the gelatine till soft, then add the above, stir
all well together, and pour into a mould and let stand till it is very
cold. One pound of prunes, well washed, then covered with water
and allowed to soak for six hours. Put on to boil in same water until
tender; add sugar, and boil ten minutes; strain and remove stones.
Take gelatine soaked in one cup of water. Put on stove juice from
prunes equal to two and a half cupfuls; add juice of lemon and
orange. When this commences to boil add gelatine and prunes. Turn
into mould and serve when cold with whipped cream. One pound of
stewing prunes, wash well and leave them to soak about an hour. In
the meantime put half a package of gelatine to soak, then take the
prunes and put them on a saucepan on the fire, well covered with
water and about half a cupful of sugar. Boil for about an hour. Strain
the juice from the prunes, then add the gelatine to the juice and put
on the fire to boil up. Cover the prunes with the juice and gelatine
mixed, put in hot in a mould and leave till cold. Serve with whipped
cream. PRUNE JELLY 1 lb. prunes. 1 lb. sugar. 1 oz. gelatine. 1
orange. 1 lemon. Whipped cream. PRUNE JELLY APPLE SPONGE 1 lb.
apples. J oz. gelatine. 1 lb. sugar. Juice of 2 lemons. Kind of 1
lemon. J pt. boiling water.
246 DESSERTS, CUSTARDS AND CREAMS Boil the water
and sugar in a saucepan until dissolved. Peel and slice the apples
thinly, and add to the syrup, and stew until tender. Add gelatine, and
strain all through a sieve; add lemon juice and rind and beat until
cool. Beat the whites of three eggs stiffly and add to the mixture,
and beat all until cold. Put into a mould; serve with custard.
COMPOTE OF CHESTNUTS (FRANC ATELLI) 50 chestnuts. 3 oranges.
1 qt. milk and water. \ pt. cream. 12 oz. sugar. Maraschino. Oranges
quartered and soaked in maraschino. Whipped cream. Remove husks
and skin from the chestnuts, and boil gently in the milk and water
until like floury potatoes, and strain them. Boil the sugar until it purls
on the surface and flavor with vanilla bean ; add the chestnuts and
work all together vigorously, and rub through a potato masher on to
a dish. Pile up whipped cream in the centre of a dish, and gently
strew the chestnuts on top of the cream in a conical form; garnish
with orange quarters at the base of the cream and nuts. PRINCE OF
WALES DESSERT Take sponge cakes, stale preferred ; dip in sherry
or syrup and line a mould with them. Take three-quarters pound
cornflour, one ounce arrowroot, and mix together; add one pint
boiling milk and cook a few minutes; add one teaspoon vanilla and
pour this into the lined basin. When cold turn out. Put a large
spoonful of red currant jelly on the top, and sprinkle well with
chopped pistachio nuts. This may be varied by putting the cakes
soaked in raspberry juice or wine in a glass dish; fill as above over
the top of this. When cold spread whipped cream; decorate with
cherries
DESSERTS, CUSTARDS AND CREAMS 247 and chopped
citron peel. Serve very cold and in the glass dish in which it was
made. The latter looks very pretty when complete. One quart milk,
yolks two eggs, one cup white sugar, two tablespoons cornstarch,
one-half large cup of caramel. Stir all together carefully, cooking in a
double boiler. Serve cold, with whipped cream. To make the caramel.
— Two cups white sugar, one-half cup water. Put on a hot fire in a
frying-pan, and stir constantly until it burns a dark brown color and
becomes liquid. Remove from the fire and add one-half large cup of
boiling water. Set away when cool in a jar for use. .Will keep for
weeks. Pour boiling water over a quart of plums, let them stand long
enough to soften the skins, but not to break them open ; pour off
the water and when cool peel and remove the stones, taking care to
save all the juice. Soak half a box of gelatine in a cup of cold water.
Stew the plums until tender after adding a cup of water ; sweeten to
taste ; then stir the whole while hot into the gelatine. Serve with
whipped cream. Lemon juice or wine may be used with the water, if
liked. One quart of cream, one small cup of sugar, one tablespoonful
of vanilla. Mix sugar and flavoring with cream. When the sugar is
dissolved strain into the freezer. CARAMEL CUSTARD PLUM SHAPE
PHILADELPHIA ICE CREAM SPANISH CREAM 1 box gelatine. 1J pts.
milk. 3 eggs, beaten separately. 3 tablespoonfuls sugar.
248 DESSERTS, CUSTARDS AND CREAMS Dissolve gelatine
on top of kettle, boil milk ; add gelatine, stirring it in quickly, then
add yolks of eggs, beaten with sugar. When well scalded take off the
fire and stir the whites in, well beaten; flavor to taste and put into
mould. BURNT CREAM 1 qt. milk. 1 lb. brown sugar. 4 tablespoonfuls
cornstarch. -J pt. cream, whipped. A few walnut meats. Boil milk, stir
in cornstarch, add a few broken walnuts. Put in a saucepan one
pound of brown sugar, let it brown as dark as possible, then add the
milk ; after the milk is thick beat well together and turn into a
mould. Decorate with half walnuts around, or solitaire moulds with a
half walnut on top, whipped cream around dish. APPLE CHARLOTTE
\ lb. breadcrumbs. \ lb. brown sugar. 1 lb. apples. 1 grated rind of
lemon. 2 oz. suet, chopped. Butter a pie dish and sprinkle it with
sugar. Mix suet and bread-crumbs together, put a layer of apple in
small pieces, sugar and rind of lemon, then suet and crumbs; repeat
until dish is full. Bake thirty or forty minutes. Turn out. GINGER
CREAM Make a custard of a gill of milk, one ounce of sugar, the
beaten yolks of three eggs. Stir in a double boiler until thick, let it
cool, then add one gill of the syrup from the jar of preserved ginger,
and two ounces of the ginger cut up; add three-quarters ounce, full
weight, of gelatine melted in as little water as possible. Last of all
add one-half pint of
DESSERTS, CUSTARDS AND CREAMS 249 whipped cream.
Mix gently until well blended, pour into a mould and set on ice. RICH
CHOCOLATE TORTE (GERMAN) $ lb. chocolate. Yolks of 7 eggs. i lb.
pounded almonds. Bread or cracker crumbs. J lb. sugar. Beat yolks
very light with sugar, add chocolate, melted, almonds pounded, and
last the whites of eggs beaten very stiff. Butter a flat shallow pan
with unsalted butter, and sift in finely rolled cracker or bread crumbs.
Pour in the mixture and cook half an hour in a moderate oven. Must
be cut while hot into cubes. Will keep well for weeks.
The text on this page is estimated to be only 20.83%
accurate
Our website is not just a platform for buying books, but a bridge
connecting readers to the timeless values of culture and wisdom. With
an elegant, user-friendly interface and an intelligent search system,
we are committed to providing a quick and convenient shopping
experience. Additionally, our special promotions and home delivery
services ensure that you save time and fully enjoy the joy of reading.
ebookname.com